Multiple Assemblies exist for SMTL entry 9d4b
Discovery of SMD-3236, a Potent, Highly Selective and Efficacious SMARCA2 Degrader for the Treatment of SMARC4-Deficient Human Cancers; X-RAY DIFFRACTION 3.30 Å

SMTL ID 9d4b.1 Ligands (4R)-1-[(2S)-2-{4-[(1S,4S)-4-({4-[(12'S)-4'-chloro-5'-oxo-5'H-spiro[cyclohexane-1,7'-indolo[1,2-a]quinazolin]-10'-yl]piperidin-1-yl}methyl)cyclohexyl]-1H-1,2,3-triazol-1-yl}-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1R)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-2-(morpholin-4-yl)ethyl]-L-prolinamide Polypeptides von Hippel-Lindau disease tumor suppressor; Elongin-B; Elongin-C; Probable global transcription activator SNF2L2 Oligo-state hetero-1-1-1-1-mer

SMTL ID 9d4b.2 Ligands (4R)-1-[(2S)-2-{4-[(1S,4S)-4-({4-[(12'S)-4'-chloro-5'-oxo-5'H-spiro[cyclohexane-1,7'-indolo[1,2-a]quinazolin]-10'-yl]piperidin-1-yl}methyl)cyclohexyl]-1H-1,2,3-triazol-1-yl}-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1R)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-2-(morpholin-4-yl)ethyl]-L-prolinamide Polypeptides von Hippel-Lindau disease tumor suppressor; Elongin-B; Elongin-C; Probable global transcription activator SNF2L2 Oligo-state hetero-1-1-1-1-mer